cyclophosphamide,fludarabine,lisocabtagene maraleucel
bms
['leusm', 'transcend,(-nhl-001),(-nhl 001),(-nhl001),(-nhl-006),(-nhl 006),(-nhl006),(-pilot-017006),(-pilot017006),(-pilot 017006)', 'transcend fl', 'lymsm', 'liso-cel']
congress #17icml| late-breaking abstract
franck morschhauser at centre hospitalier universitaire de lille presented phase 2 transcend fl study of liso-cel in pts with r/r fl. orr=97%, cr=94% with low rates of gr 3 teaes of crs/nes, prolonged cytopenia, &amp; infection #lymsm #leusm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm